In contrast, TNFα blockers have been essential in managing rheumatoid arthritis and Crohn’s disease by inhibiting proinflammatory cytokines, later expanding to conditions like psoriatic arthritis (33, 34). The gene discussed is TNF; the disease is Crohn disease.